TY - JOUR AU - Liu, Y. AU - Yan, L. AU - Wan, L. AU - Xiang, T. AU - Le, A. AU - Liu, J. PY - 2020 DA - 2020// TI - Viral dynamics in mild and severe cases of COVID-19 JO - Lancet Infect Dis VL - 20 UR - https://doi.org/10.1016/S1473-3099(20)30232-2 DO - 10.1016/S1473-3099(20)30232-2 ID - Liu2020 ER - TY - JOUR AU - Mehta, P. AU - McAuley, D. F. AU - Brown, M. AU - Sanchez, E. AU - Tattersall, R. S. AU - Manson, J. J. PY - 2020 DA - 2020// TI - COVID-19: consider cytokine storm syndromes and immunosuppression JO - Lancet VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30628-0 DO - 10.1016/S0140-6736(20)30628-0 ID - Mehta2020 ER - TY - STD TI - Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844-47.  https://doi.org/10.1111/jth.14768. ID - ref3 ER - TY - JOUR AU - Ye, Q. AU - Wang, B. AU - Mao, J. PY - 2020 DA - 2020// TI - The pathogenesis and treatment of the ‘ cytokine storm ’ in COVID-19 JO - J Inf Secur VL - 80 ID - Ye2020 ER - TY - JOUR AU - Huang, C. AU - Wang, Y. AU - Li, X. AU - Ren, L. AU - Zhao, J. AU - Hu, Y. PY - 2020 DA - 2020// TI - Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China JO - Lancet VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30183-5 DO - 10.1016/S0140-6736(20)30183-5 ID - Huang2020 ER - TY - JOUR AU - Hoffmann, M. AU - Kleine-Weber, H. AU - Schroeder, S. AU - Krüger, N. AU - Herrler, T. AU - Erichsen, S. PY - 2020 DA - 2020// TI - SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor JO - Cell VL - 181 UR - https://doi.org/10.1016/j.cell.2020.02.052 DO - 10.1016/j.cell.2020.02.052 ID - Hoffmann2020 ER - TY - BOOK AU - Cheng, H. AU - Wang, Y. AU - Wang, G. Q. PY - 2020 DA - 2020// TI - Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19 ID - Cheng2020 ER - TY - JOUR AU - Tang, N. AU - Bai, H. AU - Chen, X. AU - Gong, J. AU - Li, D. AU - Sun, Z. PY - 2020 DA - 2020// TI - Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy JO - J Thromb Haemost VL - 18 UR - https://doi.org/10.1111/jth.14817 DO - 10.1111/jth.14817 ID - Tang2020 ER - TY - STD TI - Ackermann M, Verleden S, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular Endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020. ID - ref9 ER - TY - CHAP AU - Bakheit, A. H. H. AU - Al-Hadiya, B. M. H. AU - Abd-Elgalil, A. A. PY - 2014 DA - 2014// TI - Azithromycin BT - Profiles of drug substances, excipients and related methodology ID - Bakheit2014 ER - TY - JOUR AU - Zarogoulidis, P. AU - Papanas, N. AU - Kioumis, I. AU - Chatzaki, E. AU - Maltezos, E. AU - Zarogoulidis, K. PY - 2012 DA - 2012// TI - Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases JO - Eur J Clin Pharmacol VL - 68 UR - https://doi.org/10.1007/s00228-011-1161-x DO - 10.1007/s00228-011-1161-x ID - Zarogoulidis2012 ER - TY - JOUR AU - Kawamura, K. AU - Ichikado, K. AU - Takaki, M. AU - Sakata, Y. AU - Yasuda, Y. AU - Shingu, N. PY - 2016 DA - 2016// TI - Efficacy of azithromycin in sepsis-associated acute respiratory distress syndrome: a retrospective study and propensity score analysis JO - Springerplus VL - 5 UR - https://doi.org/10.1186/s40064-016-2866-1 DO - 10.1186/s40064-016-2866-1 ID - Kawamura2016 ER - TY - JOUR AU - Menzel, M. AU - Akbarshahi, H. AU - Bjermer, L. AU - Uller, L. PY - 2016 DA - 2016// TI - Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients JO - Sci Rep VL - 6 ID - Menzel2016 ER - TY - JOUR AU - Gielen, V. AU - Johnston, S. L. AU - Edwards, M. R. PY - 2010 DA - 2010// TI - Azithromycin induces anti-viral responses in bronchial epithelial cells JO - Eur Respir J VL - 36 UR - https://doi.org/10.1183/09031936.00095809 DO - 10.1183/09031936.00095809 ID - Gielen2010 ER - TY - STD TI - Min JY, Jang YJ. Macrolide therapy in respiratory viral infections. Mediat Inflamm. 2012;2012:1–9. ID - ref15 ER - TY - JOUR AU - Porter, J. D. AU - Watson, J. AU - Roberts, L. R. AU - Gill, S. K. AU - Groves, H. AU - Dhariwal, J. PY - 2016 DA - 2016// TI - Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium JO - J Antimicrob Chemother VL - 71 UR - https://doi.org/10.1093/jac/dkw222 DO - 10.1093/jac/dkw222 ID - Porter2016 ER - TY - STD TI - Li C, Zu S, Deng YQ, Li D, Parvatiyar K, Quanquin N, et al. Azithromycin protects against Zika virus infection by upregulating virus-induced type I and III interferon responses. Antimicrob Agents Chemother. 2019;63(12)1–14. ID - ref17 ER - TY - JOUR AU - Madrid, P. B. AU - Panchal, R. G. AU - Warren, T. K. AU - Shurtleff, A. C. AU - Endsley, A. N. AU - Green, C. E. PY - 2016 DA - 2016// TI - Evaluation of Ebola virus inhibitors for drug repurposing JO - ACS Infect Dis VL - 1 UR - https://doi.org/10.1021/acsinfecdis.5b00030 DO - 10.1021/acsinfecdis.5b00030 ID - Madrid2016 ER - TY - JOUR AU - Touret, F. AU - Gilles, M. AU - Barral, K. AU - Nougairède, A. AU - Helden, J. AU - Decroly, E. PY - 2020 DA - 2020// TI - In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication JO - Sci Rep VL - 10 UR - https://doi.org/10.1038/s41598-020-70143-6 DO - 10.1038/s41598-020-70143-6 ID - Touret2020 ER - TY - STD TI - Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382(19):1787-99. https://doi.org/10.1056/NEJMoa2001282. ID - ref20 ER - TY - JOUR AU - Kahan, B. C. AU - Jairath, V. AU - Doré, C. J. AU - Morris, T. P. PY - 2014 DA - 2014// TI - The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies JO - Trials. VL - 15 UR - https://doi.org/10.1186/1745-6215-15-139 DO - 10.1186/1745-6215-15-139 ID - Kahan2014 ER - TY - CHAP AU - Rubin, D. B. ED - Rubin, D. B. PY - 1987 DA - 1987// TI - Multiple imputation for nonresponse in surveys [Internet] BT - Wiley Series in Probability and Statistics PB - Wiley CY - Hoboken UR - https://doi.org/10.1002/9780470316696 DO - 10.1002/9780470316696 ID - Rubin1987 ER - TY - JOUR AU - Zhou, F. AU - Yu, T. AU - Du, R. AU - Fan, G. AU - Liu, Y. AU - Liu, Z. PY - 2020 DA - 2020// TI - Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study JO - Lancet. VL - 395 UR - https://doi.org/10.1016/S0140-6736(20)30566-3 DO - 10.1016/S0140-6736(20)30566-3 ID - Zhou2020 ER - TY - JOUR AU - Guo, D. AU - Cai, Y. AU - Chai, D. AU - Liang, B. AU - Bai, N. AU - Wang, R. PY - 2010 DA - 2010// TI - The cardiotoxicity of macrolides: a systematic review JO - Pharmazie. VL - 65 ID - Guo2010 ER - TY - JOUR AU - Rubinstein, E. PY - 2001 DA - 2001// TI - Comparative safety of the different macrolides JO - Int J Antimicrob Agents VL - 18 UR - https://doi.org/10.1016/S0924-8579(01)00397-1 DO - 10.1016/S0924-8579(01)00397-1 ID - Rubinstein2001 ER - TY - STD TI - Zimmermann P, Ziesenitz VC, Curtis N, Ritz N. The immunomodulatory effects of macrolides-a systematic review of the underlying mechanisms. Front Immunol. 2018;9(302):1–14.  Available from: https://pubmed.ncbi.nlm.nih.gov/29593707. UR - https://pubmed.ncbi.nlm.nih.gov/29593707 ID - ref26 ER - TY - JOUR AU - Paolo, A. AU - Barbara, C. AU - Chella, A. AU - Angeletti, C. A. AU - Tacca, M. PY - 2002 DA - 2002// TI - Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily JO - Pharmacol Res VL - 46 UR - https://doi.org/10.1016/S1043661802002384 DO - 10.1016/S1043661802002384 ID - Paolo2002 ER - TY - JOUR AU - Danesi, R. AU - Lupetti, A. AU - Barbara, C. AU - Ghelardi, E. AU - Chella, A. AU - Malizia, T. PY - 2003 DA - 2003// TI - Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg JO - J Antimicrob Chemother VL - 51 UR - https://doi.org/10.1093/jac/dkg138 DO - 10.1093/jac/dkg138 ID - Danesi2003 ER - TY - JOUR AU - Metlay, J. P. AU - Waterer, G. W. AU - Long, A. C. AU - Anzueto, A. AU - Brozek, J. AU - Crothers, K. PY - 2019 DA - 2019// TI - Diagnosis and treatment of adults with community-acquired pneumonia JO - Am J Respir Crit Care Med VL - 200 UR - https://doi.org/10.1164/rccm.201908-1581ST DO - 10.1164/rccm.201908-1581ST ID - Metlay2019 ER - TY - JOUR AU - Kim, H. C. AU - Kang, S. H. PY - 2009 DA - 2009// TI - Total synthesis of azithromycin JO - Angew Chem Int Ed VL - 48 UR - https://doi.org/10.1002/anie.200805334 DO - 10.1002/anie.200805334 ID - Kim2009 ER -